A month after claiming a link between Tylenol use and autism, Health Secretary Robert F. Kennedy Jr. now says there's 'not ...

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...

Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...

Personal healthcare products provider Kenvue Inc. (NYSE:KVUE) has been in the news for one reason or another recently.

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Canadian pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while ...